Partially Replicate Bioequivalence Study of Quetiapine 25 mg in Healthy Volunteers Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 19, 2021

Primary Completion Date

June 3, 2021

Study Completion Date

June 3, 2021

Conditions
Bioequivalence
Interventions
DRUG

Test product (T) 25 mg Film Coated Tablets

Film Coated Tablets products containing 25 mg Quetiapine

DRUG

Reference product (R) 25 mg Film Coated Tablets

Reference product (R) 25 mg Film Coated Tablets

Trial Locations (1)

Unknown

Future Research Center (FRC), Cairo

All Listed Sponsors
lead

Future University in Egypt

OTHER